Right ventricular outflow tract obstruction risk factors: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease including | A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease including right ventricular outflow tract obstruction. <ref name="pmid19121250">{{cite journal| author=Wichman CL, Moore KM, Lang TR, St Sauver JL, Heise RH, Watson WJ| title=Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. | journal=Mayo Clin Proc | year= 2009 | volume= 84 | issue= 1 | pages= 23-7 | pmid=19121250 | doi= | pmc=PMC2664566 | url= }} </ref> | ||
==References== | ==References== | ||
Revision as of 17:01, 7 November 2013
|
Right ventricular outflow tract obstruction Microchapters |
|
Classification |
|---|
|
Differentiating Right ventricular outflow tract obstruction from other Diseases |
|
Diagnosis |
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Right ventricular outflow tract obstruction risk factors On the Web |
|
FDA on Right ventricular outflow tract obstruction risk factors |
|
CDC on Right ventricular outflow tract obstruction risk factors |
|
Right ventricular outflow tract obstruction risk factors in the news |
|
Blogs on Right ventricular outflow tract obstruction risk factors |
|
Directions to Hospitals Treating Right ventricular outflow tract obstruction risk factors |
|
Risk calculators and risk factors for Right ventricular outflow tract obstruction risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease including right ventricular outflow tract obstruction. [1]